Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Journal of Clinical Pharmacology|August 3, 2004
Pharmacological and clinical profile of moexipril: a concise reviewSteven G Chrysant, George S ChrysantExpert Review of Cardiovascular Therapy|March 23, 2022
Beneficial cardiovascular and remodeling effects of SGLT 2 inhibitorsSteven G Chrysant, George S ChrysantExpert Review of Cardiovascular Therapy|July 7, 2018
The current status of homocysteine as a risk factor for cardiovascular disease: a mini reviewSteven G Chrysant, George S ChrysantExpert Opinion on Drug Safety|December 5, 2019
Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemiaSteven G Chrysant, George S ChrysantJournal of Clinical Hypertension (Greenwich, Conn.)|July 3, 2013
An update on the cardiovascular pleiotropic effects of milk and milk productsSteven G Chrysant, George S ChrysantThe American Journal of Cardiology|March 20, 2012
Clinical implications of cardiovascular preventing pleiotropic effects of dipeptidyl peptidase-4 inhibitorsSteven G Chrysant, George S ChrysantCurrent Hypertension Reports|December 3, 2014
Dual renin-angiotensin-aldosterone blockade: promises and pitfallsSteven G Chrysant, George S ChrysantHospital Practice (1995)|February 5, 2019
Obesity-related heart failure with preserved ejection fraction: new treatment strategiesSteven G Chrysant, George S ChrysantJournal of Clinical Hypertension (Greenwich, Conn.)|December 31, 2013
The age-related hemodynamic changes of blood pressure and their impact on the incidence of cardiovascular disease and stroke: new evidenceSteven G Chrysant, George S ChrysantJournal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2004
Clinical experience with angiotensin receptor blockers with particular reference to valsartanSteven G Chrysant, George S ChrysantPageof 12